Have you had a confirmed diagnosis of COVID-19 or were you exposed to someone with COVID-19 and want to be part of this study? You may be eligible if you are between the ages of 18-89 who live in one of the metro areas listed below.
If you are eligible to enroll and live within approximately 60 miles of the following cities, we will make every effort to come to your house, resources permitting.
Open to some cohorts
Closed (thank you!)
Kansas City, KS
New Brunswick, NJ
Los Angeles, CA
New York, NY
Baton Rouge, LA
San Diego, CA
San Francisco, CA
What to expect with participation in this study
Read the consent form and decide whether you want to participate in the study. If so, then complete a quick survey to see if you meet the eligibility requirements for the study.
If you qualify, you will take an online questionnaire.
This electronic questionnaire will be administered during the study to collect information about your medical history, symptoms, and diagnostic tests performed for COVID-19. All information provided will be de-identified in accordance with HIPAA standards.
A mobile phlebotomist will work with you to schedule a visit to your house or location of your choice to collect a blood sample and nose or throat swab for the study. This visit with trained study staff is compliant with stay-at-home-orders and social distancing as it relates to healthcare and essential services. At the end of your visit, you will receive a $50 gift card for your participation in this study.
Are you eligible?
Have you been diagnosed with COVID-19 (currently have symptoms or have recovered) or were you exposed to someone with a confirmed diagnosis of COVID-19 within the last 2 weeks?
We’re looking for adults between the ages of 18-89 who live in the metro areas listed at the top of this page.
Participants will receive a $50 gift card after you complete a questionnaire, blood draw, and nose or throat swab.
Browse and download these study documents
Sign up to hear more about ImmuneRACE
Stay informed about our data, additional locations, and more.